Home LiteratureArticle Details
PMID: 25081814 Published · epublish English Journal Article Research Support, American Recovery and Reinvestment Act Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1.

Nature communications ·Vol. 5 ·2014-08-01 ·Pages 4589

Flores-Otero J, Ahn KH, Delgado-Peraza F, Mackie K, Kendall DA, Yudowski GA

Abstract

G protein-coupled receptors (GPCRs) are the major transducers of external stimuli and key therapeutic targets in many pathological conditions. When activated by different ligands, one receptor can elicit multiple signalling cascades that are mediated by G proteins or β-arrestin, a process defined as functional selectivity or ligand bias. However, the dynamic mechanisms underlying β-arrestin signalling remain unknown. Here by studying the cannabinoid receptor 1 (CB1R), we identify ligand-specific endocytic dwell times, that is, the time during which receptors are clustered into clathrin pits together with β-arrestins before endocytosis, as the mechanism controlling β-arrestin signalling. Agonists inducing short endocytic dwell times produce little or no β-arrestin signalling, whereas those eliciting prolonged dwell times induce robust signalling. Remarkably, extending CB1R dwell times by preventing endocytosis substantially increased β-arrestin signalling. These studies reveal how receptor activation translates into β-arrestin signalling and identify a mechanism to control this pathway.

MeSH Terms
Animals Arachidonic Acids/pharmacology Arrestins/genetics,metabolism Benzoxazines/pharmacology Cannabinoid Receptor Agonists/pharmacology Clathrin/genetics,metabolism Embryo, Mammalian Endocannabinoids/pharmacology Endocytosis/drug effects,physiology Gene Expression Regulation Glycerides/pharmacology HEK293 Cells Hippocampus/cytology,drug effects,metabolism Humans Ligands Morpholines/pharmacology Naphthalenes/pharmacology Neurons/cytology,drug effects,metabolism Primary Cell Culture RNA, Small Interfering/genetics,metabolism Rats Receptor, Cannabinoid, CB1/antagonists & inhibitors,genetics,metabolism Signal Transduction Time Factors Transport Vesicles/drug effects,metabolism beta-Arrestins
Chemicals
Arachidonic Acids Arrestins Benzoxazines Cannabinoid Receptor Agonists Clathrin Endocannabinoids Glycerides Ligands Morpholines Naphthalenes RNA, Small Interfering Receptor, Cannabinoid, CB1 beta-Arrestins (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone glyceryl 2-arachidonate
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Flores-Otero Jacqueline
1] Department of Anatomy and Neurobiology, University of Puerto Rico, Medical Sciences Campus, PO Box 365067, San Juan 00936, Puerto Rico [2].
Ahn Kwang H
1] Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269, USA [2].
Delgado-Peraza Francheska
1] Department of Anatomy and Neurobiology, University of Puerto Rico, Medical Sciences Campus, PO Box 365067, San Juan 00936, Puerto Rico [2] Institute of Neurobiology, University of Puerto Rico, Medical Sciences Campus, 201 Boulevard del Valle, San Juan 00901, Puerto Rico.
Mackie Ken
Department of Psychological and Brain Sciences, Gill Center for Biomedical Sciences, Indiana University, Bloomington, Indiana 47405, USA.
Kendall Debra A
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269, USA.
Yudowski Guillermo A
1] Department of Anatomy and Neurobiology, University of Puerto Rico, Medical Sciences Campus, PO Box 365067, San Juan 00936, Puerto Rico [2] Institute of Neurobiology, University of Puerto Rico, Medical Sciences Campus, 201 Boulevard del Valle, San Juan 00901, Puerto Rico.
References (69)
69 references, click to expand
  1. Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization.
    J Biol Chem. 1999 Nov 5;274(45):32248-57 PMID: 10542263
  2. Divergent modes for cargo-mediated control of clathrin-coated pit dynamics.
    Mol Biol Cell. 2013 Jun;24(11):1725-34, S1-12 PMID: 23536704
  3. Distinct modes of regulated receptor insertion to the somatodendritic plasma membrane.
    Nat Neurosci. 2006 May;9(5):622-7 PMID: 16604070
  4. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.
    Neuropharmacology. 2008 Jan;54(1):36-44 PMID: 17681354
  5. Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition.
    J Pharmacol Exp Ther. 2000 Oct;295(1):328-36 PMID: 10991998
  6. Endocytosis by random initiation and stabilization of clathrin-coated pits.
    Cell. 2004 Sep 3;118(5):591-605 PMID: 15339664
  7. Measuring the hierarchy of molecular events during clathrin-mediated endocytosis.
    Traffic. 2011 Jul;12(7):815-25 PMID: 21447041
  8. Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.
    J Biol Chem. 1998 Jul 3;273(27):16865-73 PMID: 9642247
  9. Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin.
    Sci Signal. 2011 Aug 9;4(185):ra51 PMID: 21868357
  10. Endocannabinoid signaling and synaptic function.
    Neuron. 2012 Oct 4;76(1):70-81 PMID: 23040807
  11. Physiological and pharmacological implications of beta-arrestin regulation.
    Pharmacol Ther. 2009 Mar;121(3):285-93 PMID: 19100766
  12. Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus.
    Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):93-8 PMID: 11134505
  13. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization.
    Science. 1996 Jan 19;271(5247):363-6 PMID: 8553074
  14. Β-arrestin: a signaling molecule and potential therapeutic target for heart failure.
    J Mol Cell Cardiol. 2011 Oct;51(4):534-41 PMID: 21074538
  15. Endosomes: a legitimate platform for the signaling train.
    Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17615-22 PMID: 19822761
  16. Cannabinoid receptors: where they are and what they do.
    J Neuroendocrinol. 2008 May;20 Suppl 1:10-4 PMID: 18426493
  17. {Beta}-blocker drugs mediate calcium signaling in native central nervous system neurons by {beta}-arrestin-biased agonism.
    Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21028-33 PMID: 21078978
  18. β-Arrestin-mediated receptor trafficking and signal transduction.
    Trends Pharmacol Sci. 2011 Sep;32(9):521-33 PMID: 21680031
  19. Molecular mechanism and physiological functions of clathrin-mediated endocytosis.
    Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):517-33 PMID: 21779028
  20. Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code.
    J Biol Chem. 2011 Apr 1;286(13):11506-18 PMID: 21177246
  21. Phosphatidylinositol-(4,5)-bisphosphate regulates clathrin-coated pit initiation, stabilization, and size.
    Mol Biol Cell. 2011 Jul 15;22(14):2588-600 PMID: 21613550
  22. Minireview: More than just a hammer: ligand "bias" and pharmaceutical discovery.
    Mol Endocrinol. 2014 Mar;28(3):281-94 PMID: 24433041
  23. Investigating G protein-coupled receptor endocytosis and trafficking by TIR-FM.
    Methods Mol Biol. 2011;756:325-32 PMID: 21870236
  24. Fast modulation of μ-opioid receptor (MOR) recycling is mediated by receptor agonists.
    J Biol Chem. 2012 Apr 27;287(18):14782-91 PMID: 22378794
  25. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.
    Nature. 1996 Oct 3;383(6599):447-50 PMID: 8837779
  26. The first five seconds in the life of a clathrin-coated pit.
    Cell. 2012 Aug 3;150(3):495-507 PMID: 22863004
  27. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.
    Annu Rev Pharmacol Toxicol. 2012;52:179-97 PMID: 21942629
  28. Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate.
    Nature. 2013 Jul 11;499(7457):233-7 PMID: 23823722
  29. Automatic tracking of individual fluorescence particles: application to the study of chromosome dynamics.
    IEEE Trans Image Process. 2005 Sep;14(9):1372-83 PMID: 16190472
  30. Internalization and recycling of the CB1 cannabinoid receptor.
    J Neurochem. 1999 Aug;73(2):493-501 PMID: 10428044
  31. Regulation of endocytic clathrin dynamics by cargo ubiquitination.
    Dev Cell. 2012 Sep 11;23(3):519-32 PMID: 22940114
  32. Teaching old receptors new tricks: biasing seven-transmembrane receptors.
    Nat Rev Drug Discov. 2010 May;9(5):373-86 PMID: 20431569
  33. Cargo and dynamin regulate clathrin-coated pit maturation.
    PLoS Biol. 2009 Mar 17;7(3):e57 PMID: 19296720
  34. Therapeutic potential of β-arrestin- and G protein-biased agonists.
    Trends Mol Med. 2011 Mar;17(3):126-39 PMID: 21183406
  35. Crystal structure of the β2 adrenergic receptor-Gs protein complex.
    Nature. 2011 Jul 19;477(7366):549-55 PMID: 21772288
  36. Phosphorylation barcoding as a mechanism of directing GPCR signaling.
    Sci Signal. 2011 Aug 9;4(185):pe36 PMID: 21868354
  37. Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells.
    Neuropharmacology. 2008 Jan;54(1):45-50 PMID: 17714745
  38. CB1 cannabinoid receptor ligands.
    Mini Rev Med Chem. 2005 Jul;5(7):631-40 PMID: 16026309
  39. Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis.
    BMC Genomics. 2011 Jan 07;12:14 PMID: 21214938
  40. Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist.
    Br J Pharmacol. 2004 Jun;142(3):495-500 PMID: 15148260
  41. Beyond desensitization: physiological relevance of arrestin-dependent signaling.
    Pharmacol Rev. 2010 Jun;62(2):305-30 PMID: 20427692
  42. Quantifying the dynamic interactions between a clathrin-coated pit and cargo molecules.
    Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):E4591-600 PMID: 24218552
  43. Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor.
    Mol Cell Endocrinol. 2013 Jun 15;372(1-2):116-27 PMID: 23541635
  44. Functional selectivity and classical concepts of quantitative pharmacology.
    J Pharmacol Exp Ther. 2007 Jan;320(1):1-13 PMID: 16803859
  45. The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones.
    Br J Pharmacol. 2012 Apr;165(8):2652-9 PMID: 22014214
  46. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.
    J Biol Chem. 2012 Apr 6;287(15):12070-82 PMID: 22343625
  47. Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection.
    Sci Signal. 2011 Aug 9;4(185):ra52 PMID: 21868358
  48. The sequence of the human genome.
    Science. 2001 Feb 16;291(5507):1304-51 PMID: 11181995
  49. Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: identification of key CB1 contacts with the C-terminal helix α5 of Gαi.
    J Biol Chem. 2013 Nov 8;288(45):32449-32465 PMID: 24092756
  50. A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization.
    Mol Pharmacol. 1999 Sep;56(3):611-8 PMID: 10462549
  51. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.
    Pharmacol Rev. 2002 Jun;54(2):161-202 PMID: 12037135
  52. Desensitization of G protein-coupled receptors and neuronal functions.
    Annu Rev Neurosci. 2004;27:107-44 PMID: 15217328
  53. Generation and functional characterization of fluorescent, N-terminally tagged CB1 receptor chimeras for live-cell imaging.
    Mol Cell Neurosci. 2007 Jun;35(2):237-48 PMID: 17467290
  54. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.
    Mol Pharmacol. 2003 Jun;63(6):1256-72 PMID: 12761335
  55. The cannabinoid receptor: biochemical, anatomical and behavioral characterization.
    Trends Neurosci. 1990 Oct;13(10):420-3 PMID: 1700516
  56. Advances in analysis of low signal-to-noise images link dynamin and AP2 to the functions of an endocytic checkpoint.
    Dev Cell. 2013 Aug 12;26(3):279-91 PMID: 23891661
  57. The interaction of beta-arrestin with the AP-2 adaptor is required for the clustering of beta 2-adrenergic receptor into clathrin-coated pits.
    J Biol Chem. 2000 Jul 28;275(30):23120-6 PMID: 10770944
  58. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors.
    J Biol Chem. 2000 Jun 2;275(22):17201-10 PMID: 10748214
  59. Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1).
    J Biol Chem. 2013 Apr 5;288(14):9790-9800 PMID: 23449980
  60. Multiple mechanisms of CB1 cannabinoid receptors regulation.
    Brain Res. 2003 Aug 8;980(2):197-205 PMID: 12867259
  61. Study of G protein-coupled receptor/β-arrestin interactions within endosomes using FRAP.
    Methods Mol Biol. 2011;756:371-80 PMID: 21870240
  62. Functional selectivity in cannabinoid signaling.
    Curr Mol Pharmacol. 2008 Nov;1(3):273-84 PMID: 20021440
  63. The structural basis of agonist-induced activation in constitutively active rhodopsin.
    Nature. 2011 Mar 31;471(7340):656-60 PMID: 21389983
  64. Cargo regulates clathrin-coated pit dynamics.
    Cell. 2006 Oct 6;127(1):113-24 PMID: 17018281
  65. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.
    Pharmacol Rev. 2010 Dec;62(4):588-631 PMID: 21079038
  66. Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling.
    J Biol Chem. 2010 Mar 5;285(10):7805-17 PMID: 20048153
  67. An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor.
    Mol Pharmacol. 2007 Apr;71(4):976-84 PMID: 17182888
  68. Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism.
    J Neurochem. 2008 Jul;106(1):70-82 PMID: 18331587
  69. Distinct clathrin-coated pits sort different G protein-coupled receptor cargo.
    Traffic. 2006 Oct;7(10):1420-31 PMID: 16899088
Article Info
Journal
Nature communications
Abbr.
Nat Commun
ISSN
2041-1723
Published
2014-08-01
Epub
2014-00-01
Pages
4589
Language
English
Region
England
NLM ID
101528555
PMCID
PMC4227836
Subset
IM
Grants
NINDS NIH HHS · P30 NS069258 · United States
NIDA NIH HHS · DA023444 · United States
NIDA NIH HHS · R01DA037924 · United States
NIDA NIH HHS · DA011322 · United States
NIDA NIH HHS · R01 DA020763 · United States
NIDA NIH HHS · R01 DA037924 · United States
NIDA NIH HHS · R01 DA011322 · United States
NIDA NIH HHS · K99 DA023444 · United States
NIDA NIH HHS · R00 DA023444 · United States
NIMHD NIH HHS · G12 MD007600 · United States
NINDS NIH HHS · 1P30NS069258 · United States
NIMHD NIH HHS · 8G12-MD007600 · United States
NIDA NIH HHS · K05 DA021696 · United States
NIDA NIH HHS · DA021696 · United States
NIDA NIH HHS · DA020763 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com